Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2Phase 3 Interventional

DMSO Cryopreserved Platelets in Cardiopulmonary Bypass Surgery (CRYPTICS)

ClinicalTrials.gov ID: NCT04709705

Public ClinicalTrials.gov record NCT04709705. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 29, 2026, 2:58 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Randomized Controlled Trial Comparing Dimethyl Sulfoxide Cryopreserved Platelets to Liquid Stored Platelets in Patients Undergoing Cardiopulmonary Bypass Surgery (CRYPTICS)

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

A randomized, parallel group, active comparator-controlled trial to evaluate the non-inferiority or superiority of Cryopreserved Platelets with Liquid Stored Platelets in controlling blood loss in patients undergoing Cardiopulmonary Bypass Surgery.

Study identification

NCT ID
NCT04709705
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2, Phase 3
Lead sponsor
Cellphire Therapeutics, Inc.
Industry
Enrollment
161 participants

Conditions and interventions

Interventions

Biological

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Oct 27, 2021 (Actual)
Primary completion
May 8, 2025 (Actual)
Completion
May 8, 2025 (Actual)
Last update posted
Oct 1, 2025

2021 – 2025

United States locations

U.S. sites
16
U.S. states
13
U.S. cities
15
Facility City State ZIP Site status
University of Alabama Birmingham Alabama 35205 —
University of Colorado Aurora Colorado 80045 —
George Washington University Washington D.C. District of Columbia 20037 —
UF Health Gainesville Florida 32608 —
Maine Medical Center Portland Maine 04102 —
University of Maryland Medical Center Baltimore Maryland 21201 —
Johns Hopkins University Baltimore Maryland 21218 —
Dartmouth Hitchcock Medical Center Lebanon New Hampshire 03756 —
Duke University Hospital Durham North Carolina 27710 —
The Ohio State Univ. Wexner Medical Center Columbus Ohio 43210 —
OU Medical Center Oklahoma City Oklahoma 73104 —
Oregon Health and Science University Portland Oregon 97239 —
Abington Memorial Hospital Abington Pennsylvania 19001 —
Thomas Jefferson Univ. Hospital Philadelphia Pennsylvania 19107 —
University of Virginia Medical Center Charlottesville Virginia 22908 —
Inova Cardiac Vascular Falls Church Virginia 22042 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT04709705, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Oct 1, 2025 · Synced Oct 29, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT04709705 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →